Blog
RSS FeedPosted by Michael Wonder on 10 Jul 2020
Drug Utilisation Sub-Committee utilisation analysis public release documents
10 July 2020 - The utilisation analysis public release documents from the February 2020 Drug Utilisation Sub-Committee meeting are now available. ...
Posted by Michael Wonder on 08 Jul 2020
So just who do we think qualifies for any COVID-19 vaccine?
9 July 2020 - How should we allocate scarce medical resources? ...
Posted by Michael Wonder on 06 Jul 2020
Better protection against meningococcal and pneumococcal diseases
6 July 2020 - The National Immunisation Program has been amended from 1 July 2020 to improve protection for those most ...
Posted by Michael Wonder on 03 Jul 2020
Public Summary Documents - March 2020 PBAC meeting
3 July 2020 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the March 2020 PBAC ...
Posted by Michael Wonder on 01 Jul 2020
PBS listings to benefit Australians with type 2 diabetes and small cell lung cancer, emergency dispensing measures of PBS medicines extended
30 June 2020 - The importance of the Pharmaceutical Benefits Scheme has been underlined with new and amended medicines listings on ...
Posted by Michael Wonder on 30 Jun 2020
Schedule of Pharmaceutical Benefits - 1 July 2020
1 July 2020 - The July 2020 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 30 Jun 2020
Expansion of continued dispensing arrangements – COVID-19
1 July 2020 - The Australian Government has extended the temporary Continued Dispensing (Emergency Measures) for three months to 30 September ...
Posted by Michael Wonder on 25 Jun 2020
Price disclosure October 2020 cycle outcomes summary
25 June 2020 - The summary of price disclosure price reductions for the October 2020 Cycle has now been published. ...
Posted by Michael Wonder on 23 Jun 2020
Seventh Community Pharmacy Agreement
23 June 2020 - The Seventh Community Pharmacy Agreement is commencing 1 July 2020 and will be in place for five ...
Posted by Michael Wonder on 21 Jun 2020
'This is what life could be like': a miracle migraine drug is changing sufferer's lives but most can't afford the 'exorbitant' $800 a month price tag
20 June 2020 - "I wish people would understand that a migraine is not just a headache. It is so ...
Posted by Michael Wonder on 19 Jun 2020
Updated PBS cost recovery arrangements for 2020-21
19 June 2020 - The 2020-21 Cost Recovery Implementation Statement is now available. ...
Posted by Michael Wonder on 19 Jun 2020
Recommendations made by the PBAC – May 2020 intracycle meeting
19 June 2020 - There is actually only one recommendation. ...
Posted by Michael Wonder on 16 Jun 2020
Additional $92 million, or 5 percent, government funding for pharmaceutical wholesalers
16 June 2020 - Pharmaceutical wholesalers will receive an additional $92 million, or 5 per cent, funding from the federal ...
Posted by Michael Wonder on 14 Jun 2020
Analysis of PBAC submissions and outcomes for medicines (2010–2018)
11 June 2020 - Sean Lybrand and I reviewed the Pharmaceutical Benefits Advisory Committee submissions and their related outcomes and timelines ...
Posted by Michael Wonder on 12 Jun 2020
$18.3 billion deal struck to fund Pharmaceutical Benefits Scheme, improve indigenous health
12 June 2020 - The Morrison government will spend an additional $100 million over the next five years on medication ...